RCSB PDB - AKG Ligand Summary Page

Chemical Component Summary
Name	2-OXOGLUTARIC ACID
Identifiers	2-oxidanylidenepentanedioic acid
Formula	C₅ H₆ O₅
Molecular Weight	146.10
Type	NON-POLYMER
Isomeric SMILES	C(CC(=O)O)C(=O)C(=O)O
InChI	InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)
InChIKey	KPGXRSRHYNQIFN-UHFFFAOYSA-N

Chemical Component Summary

Name

2-OXOGLUTARIC ACID

Identifiers

2-oxidanylidenepentanedioic acid

Formula

C₅ H₆ O₅

Molecular Weight

146.10

Type

NON-POLYMER

Isomeric SMILES

C(CC(=O)O)C(=O)C(=O)O

InChI

InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)

InChIKey

KPGXRSRHYNQIFN-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	16
Chiral Atom Count	0
Bond Count	15
Aromatic Bond Count	0

Chemical Details

Formal Charge

Atom Count

Chiral Atom Count

Bond Count

Aromatic Bond Count

Drug Info: DrugBank

DrugBank ID	DB08845
Name	Oxogluric acid
Groups	experimental investigational nutraceutical
Description	Oxogluric acid (α-Ketoglutarate) is not approved for any indication in the world but is an investigational drug in the United States. In the United States a phase I clinical trial is investigating whether oxogluric acid precursors found in nutritional supplements can benefit patients with the metabolic disorder propionic acidemia. Oxogluric acid is sold as a dietary supplement to athletes to improve their performance by helping to remove excess ammonia, but it is not officially approved for this indication and only experimental studies have shown a reduction in ammonia by oxogluric acid in hemodialysis patients. Physiologically, oxogluric acid acts in the Krebs cycle as an intermediate, is involved in transamination reactions during the metabolism of amino acids, forms glutamic acid by combining with ammonia, and reduces nitrogen by combining with it as well. Several experimental studies have also shown that administration of oxogluric acid helped attenuate the decreased synthesis of muscle protein that is often seen post-surgery.
Synonyms	2-oxopentanedioic acid 2-Ketoglutaric acid α-Ketoglutarate Ketoglutaric acid alpha-Ketoglutaric acid 2-oxoglutaric acid Oxogluric acid Oxoglurate
Indication	α-α-Ketoglutarate is not approved for any indication in the world but is an investigational drug in the United States. The potential indications for α-Ketoglutarate are in patients with the metabolic disorder propionic acidemia and in trauma patients with muscle loss.
Categories	Acids, Acyclic Dicarboxylic Acids Glutarates Keto Acids Ketoglutaric Acids
CAS number	328-50-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Aspartate aminotransferase	MFENITAAPADPILGLADLFRADERPGKINLGIGVYKDETGKTPVLTSVK...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682